These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12636053)

  • 1. Novel and traditional biomarkers of bone turnover in postmenopausal women.
    Pohlídal A; Husek P; Palicka V; Slabík D; Hill M; Matucha P
    Clin Chem Lab Med; 2003 Jan; 41(1):74-8. PubMed ID: 12636053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis.
    Husek P; Svagera Z; Vsianský F; Franeková J; Simek P
    Clin Chem Lab Med; 2008; 46(10):1391-7. PubMed ID: 18844493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis.
    Schlosser K; Scigalla P
    Scand J Clin Lab Invest Suppl; 1997; 227():21-8. PubMed ID: 9127465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A; Hannon RA; Eastell R
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis.
    Yilmaz N; Bayram M; Erbåğci AB; Kilinçer MS
    Clin Chem Lab Med; 1999 Feb; 37(2):137-43. PubMed ID: 10219502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy.
    Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C
    Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
    Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
    Muñoz-Torres M; Reyes-García R; Mezquita-Raya P; Fernández-García D; Alonso G; Luna Jde D; Ruiz-Requena ME; Escobar-Jiménez F
    Maturitas; 2009 Nov; 64(3):188-92. PubMed ID: 19819089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.
    Eastell R; Robins SP; Colwell T; Assiri AM; Riggs BL; Russell RG
    Osteoporos Int; 1993 Sep; 3(5):255-60. PubMed ID: 8400607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
    Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
    J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K in combination with other biochemical markers to diagnose osteoporosis.
    Heiss C; Hoesel LM; Wehr U; Keller T; Horas U; Meyer C; Rambeck W; Schnettler R
    Biomarkers; 2004; 9(6):479-88. PubMed ID: 15849068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The short-term effects of conjugated estrogen on bone turnover in older women.
    Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.